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ABSTRACT
The rise of antimicrobial resistance demands the development of more rapid screening methods
for the detection of antimicrobial resistance in clinical samples to both give the patient the proper
treatment and expedite the treatment of patients. Cerium oxide nanoparticles may serve a useful
role in diagnostics due to their ability to exist in a mixed valence state and act as either oxidizing
agents or reducing agents. Considering that cerium oxide nanoparticles have been shown to shift
in absorbance upon oxidation, a useful method of antimicrobial resistance detection could be
based on the oxidation of cerium oxide nanoparticles. Herein, an assay is described whereby
cerium oxide nanoparticle oxidation is a function of glucose metabolism of bacterial samples in
the presence of an antimicrobial agent. Cerium oxide nanoparticles were shown to have an
absorbance in the range of 395nm upon oxidation by hydrogen peroxide whereas mixed valence
cerium oxide nanoparticles lacked an absorbance around 395nm. In the presence the hydrogen
peroxide-producing glucose oxidase and either increasing concentrations of glucose or bacterial
medium supplemented with increasing concentrations of glucose, cerium oxide nanoparticles
were shown to increase in absorbance at 395nm. This oxidation assay was capable of measuring
differences in the absorbance of E. coli and S. aureus samples grown in the presence of
inhibitory and non-inhibitory concentrations of ampicillin in as little as six hours. Therefore, this
cerium oxide nanoparticle oxidation assay may be very useful for use in clinical laboratories for
the detection of antimicrobial resistance due to the relatively low cost, no requirement for
specialized equipment and, most importantly, the reduced incubation time of the assay to as little
as six hours compared to current gold standard antimicrobial resistance detection methods that
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require 24 hours. This assay may thus also help partially circumvent the issue of knowledge of
antimicrobial resistance in infected patients before prescribing improper regimens.
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INTRODUCTION
Background
The use of antimicrobials has vastly reduced the morbidity and mortality associated with many
infectious diseases (1). However, the rise of antimicrobial resistance in bacteria now poses a
major threat to public health and has even threatened antibiotic efficacy in treating infectious
diseases (2, 3). Many bacteria are becoming resistant to the most commonly used antimicrobial
treatments, which not only increases the risk of serious infections in the human population but
also the spread of these antimicrobial resistant bacteria throughout the human population (3). In
addition to the development of novel antimicrobials, faster and more sensitive antimicrobial
resistance screening tests are needed. These improved tests will not only expedite the diagnosis
of antimicrobial susceptibility in infected patients but also allow the proper antimicrobial
treatment to be administered rather than using a broad-spectrum antimicrobial based on disease
symptoms or diagnosis without knowledge of antimicrobial susceptibility of the infectious agent.
Currently, two of the gold standards for antimicrobial resistance detection are the disk diffusion
(Kirby-Bauer) method and the minimum inhibitory concentration (M.I.C.) (4). Despite their
effectiveness and, both of these tests require approximately 24 hours for a definitive result (4),
and sometimes the patient may not have this amount of time to spare. Therefore, a novel method
is needed that is much faster and does not compromise sensitivity or specificity.
Recently, new antimicrobial resistance detection methods have been developed that can
give results in as little as three hours (5, 6). These methods use nanoparticles as diagnostic agents
to detect antimicrobial resistance using methods such as shifts in surface resonance or magnetic
relaxometry (5, 6). However, these methods require specialized, expensive materials and
1

equipment. In this study, we planned to develop an innovative type of nanoparticle-based
detection test for antimicrobial resistance that uses a cheaper and more common method of
detection that can be adapted for use in a clinical laboratory setting.
Cerium oxide nanoparticles may offer a useful role in molecular diagnostics. Cerium
oxide nanoparticles exist in a mixed valence state between the 3+ cerium state (as Ce2O3) and 4+
cerium state (as CeO2) (Figure 1), making cerium oxide nanoparticles useful as both reducing
and oxidizing agents, depending on the ionic state (7, 8). Cerium oxide nanoparticles have also
been shown to shift in absorbance in the ultraviolet region upon oxidation/reduction, which
allows the change in valence state to be detected using a spectrophotometer (9). Therefore, a
spectrophotometer-based diagnostic assay could be developed that detects changes in the redox
state of the cerium oxide nanoparticles in order to identify the presence of antimicrobial
resistance. These cerium oxide nanoparticles thus have the capability to be used in a range of
molecular diagnostic assays, including antimicrobial resistance detection.
To detect the presence of antimicrobial resistance, an assay is needed that can either
oxidize or reduce the cerium oxide nanoparticles, and then measure this change
spectrophotometrically. In this study, we propose using mixed valence cerium oxide
nanoparticles, which can be oxidized in the presence of an oxidizing agent such as hydrogen
peroxide (H2O2) (7). The presence of H2O2 may thus cause the absorbance of the nanoparticles to
change at a specific wavelength, which can be detected by a spectrophotometer. Rather than
directly adding H2O2 to the cerium oxide nanoparticles, the oxidation of the nanoparticles can be
coupled to bacterial metabolism in an assay using glucose oxidase. Glucose oxidase is an
enzyme that catalyzes the conversion of glucose to D-glucono-1,5-lactone and H2O2 (10). This
2

H2O2 product can then oxidize the cerium oxide nanoparticles (Figure 2). We hypothesized that
the amount of H2O2 produced would be dependent on the amount of glucose present in the
medium; if the bacteria are resistant to the antimicrobial agent, the bacteria would continue to
grow and metabolize the glucose, leaving little glucose behind for glucose oxidase to produce
H2O2 and consequently oxidize the cerium oxide nanoparticles (Figure 3a). However, bacteria
that are susceptible to the antimicrobial agent would stop growing and thus fail to metabolize the
glucose. Therefore, more H2O2 will be produced, which would then oxidize a greater amount of
the cerium oxide nanoparticles (Figure 3b). As a result, the absorbance change would be much
greater for antimicrobial-susceptible bacteria than if the bacteria were resistant to the
antimicrobial agent. This method was expected to be more rapid than the zone of clearing and
turbidity-based methods of detection associated with the Kirby-Bauer and M.I.C. tests,
respectively. Furthermore, the hypothesized assay would require no specialized equipment other
than cerium oxide nanoparticles and a spectrophotometer. This method may thus offer a quicker
detection method without requiring expensive materials or equipment while also being
compatible for high-throughput screening methods.
Hypothesis
The hypothesis for this experiment was that cerium oxide nanoparticles can be used for the
detection of antimicrobial resistance by measuring the absorbance change of the cerium oxide
nanoparticles upon oxidation by the H2O2 produced in the glucose oxidase-catalyzed oxidation of
glucose. This process would be dependent on the amount of glucose present in the medium and
thus the metabolic activity of the bacteria.
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Specific Aims
The specific aims for this experiment were:
1) Determine if the absorption spectrum of the cerium oxide nanoparticles changes upon the
addition of H2O2, and then determine the wavelength at which the absorbance of the oxidized
cerium oxide nanoparticles (CeO2) is greater than the absorbance of the mixed valence state
nanoparticles.
2) Determine if the absorbance change for the cerium oxide nanoparticles upon oxidation occurs
in the presence of glucose oxidase in a glucose-containing medium, such as the bacterial medium
Muller-Hinton (MH) broth supplemented with a defined concentration of glucose.
3) Determine if antimicrobial susceptible and resistant bacteria, when grown in a glucosecontaining medium, produce different absorbance changes in the cerium oxide nanoparticles
upon the addition of glucose oxidase.
Reduction

Ce2O3

CeO2

Oxidation
Figure 1: Mixed Valence State of Cerium Oxide Nanoparticles
Ionic cerium exists in a mixed-valence state between the 3+ (as Ce2O3) and 4+ (as CeO2) states.
Ionic cerium can thus change its ionic state in the presence of mild oxidizing or reducing agents,
altering the spectral properties of the cerium oxide nanoparticles.
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Glucose Oxidase
β-D-glucose + O2 + H2O

D-glucono-1,5-lactone + H2O2
Ce2O3

CeO2
O2 + H2O
Figure 2: Chemical Reactions of the Hypothesized Oxidation Assay for Cerium Oxide
Nanoparticles
Glucose oxidase is an enzyme that converts β-D-glucose to D-glucono-1,5-lactone and H2O2.
The H2O2 product is then capable of oxidizing cerium oxide nanoparticles in the 3+ ionic state to
the 4+ ionic state.
a)
MH Broth
with glucose
and antibiotic
Bacterial metabolism due to
antimicrobial resistance

Glucose
Bacteria
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Very little glucose for oxidation
Low CeO2 produced
Low Absorbance

b)

No bacterial metabolism due to
antimicrobial sensitivity





High amount of glucose for oxidation
High CeO2
High Absorbance

Figure 3: Proposed Model of Glucose Utilization by Sensitive versus Resistant Strains of
Bacteria and the Effect on Cerium Oxide Nanoparticle Oxidation and Absorbance.
a) If the bacteria are resistant to the antimicrobial, the bacteria will continue to metabolize the
glucose present in the medium. This will cause the amount of glucose to decrease over time,
leaving less glucose substrate for glucose oxidase to produce H2O2. There will be little oxidation
of Ce2O3 to CeO2 and thus very little increase in absorbance.
b) If the bacteria are sensitive to the antimicrobial, bacterial metabolism will be halted. The
amount of glucose in the medium will not markedly decrease, so there will be much glucose
substrate for glucose oxidase to produce H2O2, which will in turn oxidize Ce2O3 to CeO2.
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MATERIALS AND METHODS
Preparation of Polyacrylic Acid-Coated Cerium Oxide Nanoparticles
Polyacrylic acid-coated cerium oxide nanoparticles (PAA-CONP, Batch#AA-111809) were
prepared as described (8).
Absorption Spectrum of PAA-CONP in the Presence and Absence of H2O2
The absorption spectrum of the PAA-CONP was measured in a Cary 300 Bio UV-Visible
Spectrophotometer using Cary WinUV software. A 1:1000 dilution of the PAA-CONP was
prepared and transferred to a quartz cuvette. A quartz cuvette containing 1ml of H2O was used as
a blank. Another quartz cuvette containing 1ml of H2O was used to establish a baseline
absorption spectrum. The absorption spectrum of the PAA-CONP sample was then measured.
Next, hydrogen peroxide (H2O2, Acros) was added to a final concentration of 9.71mM (0.003%)
in another quartz cuvette containing a 1:1000 dilution of the PAA-CONP, and the absorption
spectrum of this sample was immediately measured and also six minutes after the addition of
H2O2 to ensure no significant changes in the absorption spectrum of the H2O2-containing PAACONP sample occurred. It should be noted that, for this experiment only, a different batch of
PAA-CONP was used (not Batch #111809), although similar trends were seen between the two
batches in future experiments.
PAA-CONP Absorption after the Addition of H2O2 Dilutions
A 1:40 dilution of PAA-CONP was prepared. 200µl of the 1:40 dilution of PAA-CONP was
mixed with 1µl of a range of H2O2 concentrations (0.0483mM, 0.0644mM, 0.0966mM,
0.483mM, 0.644mM, 0.966mM, 1.93mM, 4.83mM, 9.66mM, and 48.3mM). 1µl of dH2O was
added to 200µl of the 1:40 dilution of PAA-CONP to serve as the blank. Samples were then
7

transferred to a clear 96-well plate (CellStar) and placed in a BioTek µQuant Plate Reader (using
Gen5 version 1.05 as the software). The absorption of the PAA-CONP was measured at 395nm,
400nm, and 410nm. The absorbance value was calculated by subtracting the absorbance of each
sample containing H2O2 from the absorbance of the sample without H2O2.
PAA-CONP Absorption in the Presence of Glucose and MH Broth Supplemented with Glucose
PAA-CONP absorption was tested in a range of glucose concentrations (0, 0.0265, 0.06625,
0.1325, 0.199, 0.265, 0.6625, 1.325, 1.99, and 2.65mM) dissolved in either H2O or MullerHinton (MH) broth (donated by the University of Central Florida’s Microbiology Prep Room).
The samples were prepared by adding 100µl of a 1:20 dilution of PAA-CONP to 100µl of a
respective glucose solution, and by adding 100µl of a 1:10 dilution of PAA-CONP to 100µl of
MH Broth supplemented with a defined concentration of glucose. Note that a 1:10 initial dilution
of PAA-CONP was used for the MH broth samples supplemented with glucose instead of a 1:20
dilution in order to improve sensitivity by increasing the final absorbance values. The samples
were then transferred to a clear 96-well plate, and the absorbance of the PAA-CONP was tested
at 395nm, 400nm, and 410nm. Next, 10µl of 1mg/ml glucose oxidase (Type X, MP Biomedicals)
was then added to the samples to bring the final volume to 210µl. 10µl of H2O was added to one
sample containing PAA-CONP and 2.65mM glucose to serve as the blank. The 96-well plate was
then placed in a BioTek µQuant Plate Reader and the absorption of the PAA-CONP was
measured at 395nm, 400nm, and 410nm.
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Bacterial Culture Preparation and Determination of PAA-CONP Absorbance in the Presence of
Bacterial Cultures Supplemented with or without an Inhibitory Concentration of Antibiotic
A stock culture of Escherichia coli strain MM 294 (ATCC 33625) was grown in Nutrient Broth
supplemented with a defined concentration of glucose to log phase growth at 37oC with shaking
(C24KC refrigerated incubator shaker, New Brunswick Scientific) as measured by OD600
measurements in a Bio-Rad SmartSpec 3000 spectrophotometer (log phase defined as no more
than 5.0×108 cells/ml or an absorbance of 1.0). A set of M.I.C. samples containing an inhibitory
concentration of ampicillin, no ampicillin, and a sterile control were prepared for various
incubation times. During log phase growth, 1ml of 1×106 E. coli cells was added to 1ml of
Nutrient Broth supplemented with a defined concentration of glucose. 50µl of a 2mg/ml solution
of ampicillin (Sigma) was added to one of the E. coli samples (50µg/ml ampicillin) and 50µl of
H2O was added to a second E. coli sample (no ampicillin). The sterile control contained 2ml of
Nutrient Broth and 50µl of 2mg/ml ampicillin (50µg/ml ampicillin) was also prepared for each
time point. An M.I.C. sample was specifically prepared for turbidity determination (and
confirmed by OD600 measurements) at 24 hours to both determine and ensure the
sensitivity/resistance profiles of the M.I.C. test. 50µg/ml ampicillin was found to be inhibitory
towards the growth of E. coli strain MM 294 after 24 hours as determined by turbidity
measurements. The M.I.C. samples were then incubated at 37oC with shaking in a C24KC
refrigerated incubator shaker (New Brunswick Scientific) for the time period of interest. M.I.C.
samples were then autoclaved after the time point of interest to inhibit further metabolism, and
then samples were centrifuged at 13,200rpm (16,100rcf) in an Eppendorf 5415D centrifuge for
two minutes to remove the bacteria from the samples. 100µl of the M.I.C. samples were then
added to 100µl of a 1:10 dilution of PAA-CONP and transferred to a clear 96-well plate. 10µl of
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1mg/ml glucose oxidase was then added to the wells. A duplicate of each sample was prepared,
but these samples had 10 µl H2O added instead of glucose oxidase to serve as a blank.
PAA-CONP Absorbance Comparison to the Minimum Inhibitory Concentration (M.I.C.)
Experiment
Stock cultures of Escherichia coli strain MM 294 (ATCC) and Staphylococcus aureus strain
25178 (ATCC) were grown in Nutrient Broth supplemented with 0.25mg/ml glucose. Cultures
were allowed to incubate at 37oC on a C24KC refrigerated incubator shaker (New Brunswick
Scientific) overnight. For E. coli, the bacteria was allowed to reach logarithmic phase growth,
but the OD600 of the S. aureus culture was determined to be greater than 1.0, so this culture may
not have been in logarithmic phase growth when used. 1ml of 1×106 of E. coli or S. aureus
cells/ml (in Nutrient Broth supplemented with 0.25mg/ml glucose) was then added to 1ml of
Nutrient Broth supplemented with 0.25mg/ml glucose. Ampicillin solutions (dissolved in
Nutrient Broth supplemented with 0.25mg/ml glucose) were then added to each tube to the
following concentrations: 0, 15, 30, 45, 60, and 75μg/ml for E. coli and 0, 0.25, 0.5, 0.75, 1, and
60μg/ml for S. aureus. Sterile controls that contained 2ml of Nutrient Broth supplemented with
0.25mg/ml glucose and either 75μg/ml ampicillin (for the E. coli sterile controls) or 60μg/ml (for
the S. aureus sterile controls) were also prepared.
Three sets of each E. coli and S. aureus samples were prepared for 4 hours, 6 hours, and
24 hours of incubation. The 4 hour and 6 hour samples were autoclaved and centrifuged at
13,200rpm (16,100rcf) in an Eppendorf 5415D centrifuge for two minutes to remove the bacteria
from the samples. 100μl of the supernatant was added to 100μl of a 1:10 dilution of PAA-CONP
and then transferred to a clear 96-well plate. The absorbance was then measured at 395nm,
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400nm, and 410nm. 10μl of 1mg/ml glucose oxidase was then added to each sample. A sample
containing 100μl of the 4 hour or 6 hour sterile control, 100μl of PAA-CONP, and 10μl of H2O
was used as a blank. The absorbance of the samples was measured immediately after the addition
of glucose oxidase as well as 15 and 30 minutes after the addition of glucose oxidase at 395nm,
400nm, and 410nm. Absorbance measurements were calculated by subtracting the absorbance of
the sample of interest by the absorbance of the same sample before the addition of glucose
oxidase and the absorbance of the blank sample.
The 24 hour M.I.C. samples were used for both turbidity determination and OD600
measurements and thus as a comparison to the results obtained for the 4 hour and 6 hour
samples. The OD600 for the 24 hour samples was determined by transferring 1ml of each M.I.C.
sample to a plastic cuvette. The OD600 was measured in a Bio-Rad SmartSpec 3000
spectrophotometer, using the sterile control as the blank.
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RESULTS
First, the absorption spectrum of mixed valence polyacrylic acid-coated cerium oxide
nanoparticles (PAA-CONP) was obtained. The PAA-CONP were then oxidized via the addition
of H2O2, and the absorption spectrum of the oxidized PAA-CONP was then measured and
compared to the absorption spectrum of the PAA-CONP without H2O2 oxidation.

PAA-CeNP

PAA-CeNP
with H2O2

dH2O

PAA-CeNP with
H2O2 after 6
minutes

Figure 4: Absorption Spectra of PAA-CONP before and after the addition of H2O2.
The absorption spectrum of PAA-CONP was before (blue line) and after (purple line) the
addition of H2O2. The absorption spectrum was also measured six minutes after the addition of
H2O2 (maroon line) to ensure no other changes in the absorption spectrum occurred over time.
The absorption spectrum of dH2O (red line) served as the baseline. Note that the absorption
spectra were measured between 200nm and 800nm, but the graph shown here only represents the
absorption spectra between 250-550nm, since this was the only range of wavelengths where
differences in the absorption spectrum of PAA-CONP with and without H2O2 could be seen.
Note that the oxidized PAA-CONP has a measurable absorbance around 400nm whereas mixed
valence PAA-CONP (no H2O2 added) does not have an absorbance in this region.
The results of the absorption spectra showed that oxidized PAA-CONP has a measurable
absorbance around 400nm whereas mixed valence PAA-CONP did not show a significant
absorbance. The slight increase in absorbance for the oxidized PAA-CONP after six minutes
12

indicated that oxidation of the PAA-CONP was still occurring. Note that there was no observable
difference in the absorption spectra of the PAA-CONP with and without H2O2 before 250nm and
between 550nm and 800nm (data not shown).
Next, the change in absorbance of the PAA-CONP around 400nm was tested by first
comparing the absorbance of the PAA-CONP at 395nm, 400nm, and 410nm incubated with
different concentrations of H2O2 to the PAA-CONP without H2O2 present.

Absorbance (arbitrary units)

Absorbance of PAA-CONP vs. [H2O2]
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
-0.1 0

395nm
y = 0.1712ln(x) + 0.5084
R² = 0.9852

400nm
y = 0.1598ln(x) + 0.4747
R² = 0.9861
395nm

410nm
y = 0.1408ln(x) + 0.4146
R² = 0.9847

400nm
410nm
Log. (395nm)
Log. (400nm)

2

4

6

Log. (410nm)

[H2O2] (mM)

Figure 5: Absorbance Values of PAA-CONP upon the Addition of Various Concentrations
of H2O2 at 395nm, 400nm, and 410nm.
The absorbance values were calculated by subtracting the absorbance of the cerium oxide
nanoparticles in the presence of no H2O2 from the absorbance of the cerium oxide nanoparticles
in the presence of H2O2. Note that the greatest absorbance values occurred at 395nm. Three
independent experiments were performed, and the average values were plotted. Error bars
represent the standard deviation for each value. The absorbance values for 9.66mM and 48.3mM
H2O2 are not shown but were still a part of the logarithmic trend seen in this figure.
The results of this experiment showed that the absorbance of PAA-CONP around 400nm
increased logarithmically as the concentration of H2O2 increased, which suggested that higher
13

concentrations of H2O2 would have a more significant impact on the absorbance until a point of
saturation was reached. Although Beer’s Law states that there is a linear relationship between
absorbance and concentration, the reason a logarithmic trend was seen between the absorbance
of the PAA-CONP and the concentration of H2O2 was that this method detects a product of a
chemical reaction (oxidized PAA-CONP). Therefore, since the product of a chemical reaction is
being detected, the kinetics should be similar to a chemical reaction, so a point of saturation is
expected to be reached after a large amount of substrate (in this case, H2O2) is added. The
highest absorbance values occurred at 395nm, so this wavelength was selected for future
experiments since this wavelength was expected to give the most sensitive results.
Due to the fact that the absorbance increased as the [H2O2] increased, the absorbance
should also increase if the [glucose] in the medium was increased because, in the presence of
glucose oxidase, the increased [glucose] would result in increased H2O2 production. Therefore,
the PAA-CONP was incubated with a range of glucose concentrations, and the A395 was
measured (Figure 6). The A395 was calculated for each sample containing glucose oxidase by
subtracting the A395 from both the absorbance the sample prior to the addition of glucose oxidase
as well as the absorbance of a blank sample containing 2.65mM glucose and PAA-CONP but no
glucose oxidase.
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a)

PAA-CONP Absorbance vs. [Glucose] at 395nm
Absorbance (arbitrary units)

0.45
0.4
0.35
0.3
0.25
0.2

15 min

0.15

30 min

0.1
0.05
0
-0.05 0

0.5

1
1.5
2
[Glucose] (mM)

2.5

15

3

b)

PAA-CONP Absorbance vs. [Glucose] before
threshold at 395nm
Absorbance (arbitrary units)

0.16
0.14
0.12
0.1

y = 0.5488x + 0.0023
R² = 0.9987
15 min

0.08
0.06
0.04

30 min
y = 0.5217x + 0.0028
R² = 0.9993

Linear (15 min)
Linear (30 min)

0.02
0
-0.02 0

0.1
0.2
[glucose] (mM)

0.3

Figure 6: PAA-CONP Oxidation by Glucose Oxidase in the Presence of Glucose Dilutions.
a) The absorbance of the CONP was measured at 395nm over a range of glucose dilutions.
Absorbance measurements were measured 15 minutes and 30 minutes after the addition of
glucose oxidase.
b) The absorbance of the CONP at 395nm without the glucose concentrations seen in the
threshold of part (a). The data shows a linear trend in absorbance versus the concentration of
glucose.
The absorbance in these figures was calculated as the absorbance of the sample of interest after
the addition of glucose oxidase minus both the absorbance of the sample before the addition of
glucose oxidase and the absorbance of a blank sample containing 2.65mM glucose and no
glucose oxidase. The CONP was diluted 42-fold in these experiments. The values shown are the
average values from three independent experiments, and error bars represent the standard
deviation for each value.
Figure 6 showed that the absorbance of the PAA-CONP at 395nm increased as the
concentration of glucose in the sample increased, which would be useful for measuring
differences in glucose levels in a bacterial medium. Furthermore, the absorbance was initially a
linear trend (as shown in part b of Figure 6) but eventually reached a threshold (as seen in Figure
6a). Therefore, quantitation of glucose levels using PAA-CONP could be possible in this small
16

range of glucose concentrations (0-0.3mM). To confirm if the absorbance of the PAA-CONP
also increased as the concentration of glucose was increased in a bacterial medium, a complex
bacterial medium (Muller-Hinton broth) was supplemented with a range of glucose
concentrations, and these samples were incubated with glucose oxidase and a 1:21 final dilution
of the PAA-CONP. The absorbance of the PAA-CONP was then measured.
a)
PAA-CONP Absorbance vs. [Glucose] in MH Broth
at 395nm
Absorbance (arbitrary units)

0.7
0.6
0.5
0.4
0.3

15 min

0.2

30 min

0.1
0
-0.1

0

0.5

1

1.5
2
[Glucose] (mM)

2.5

17
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b)

Absorbance (arbitrary units)

PAA-CONP Absorbance vs. [Glucose] in MH Broth
before threshold at 395nm
0.18
0.16
0.14
0.12
0.1
0.08
0.06
0.04
0.02
0
-0.02 0

y = 0.5538x + 0.0046
R² = 0.9976
15 min
30 min
Linear (15 min)
y = 0.5272x + 0.004
R² = 0.9969

Linear (30 min)

0.1
0.2
[Glucose] (mM)

0.3

Figure 7: A395 of PAA-CONP in the Presence of MH Broth Supplemented with Glucose and
Glucose Oxidase.
a) A395 for PAA-CONP in the presence of a range of glucose concentrations 15 minutes and 30
minutes after the addition of glucose oxidase.
b) A395 for PAA-CONP in the presence of a range of glucose concentrations 15 minutes and 30
minutes after the addition of glucose oxidase at glucose concentrations prior to the threshold seen
in part (a). Note the linear trend in absorbance as the [glucose] increases.
The A395 for both part (a) and (b) was calculated by subtracting the absorbance of the sample of
interest from both the absorbance of the sample of interest before the addition of glucose oxidase
and the absorbance of a blank sample containing PAA-CONP and MH Broth supplemented with
2.65mM glucose but no glucose oxidase. The values shown are the average values from three
independent experiments, and error bars represent the standard deviation for each value. A
similar trend in absorbance values (although the actual absorbance values were lower) were
obtained when the absorbance of the PAA-CONP was measured at 400nm and 410 nm (not
shown).
In the presence of PAA-CONP, a measurable A395 was seen, even as early as 15 minutes
after the addition of glucose oxidase. As expected, the A395 increased as the [glucose] increased
in the MH Broth. Furthermore, a point of saturation was reached, similarly to the data obtained
when PAA-CONP was oxidized by a range of H2O2 concentrations (Figure 5). Based on the
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obtained data, the glucose concentrations 0.6625mM and 1.325mM glucose were found to give
absorbance readings that were greater than 0.2, which indicated that these glucose concentrations
may produce significant differences in the A395 between bacterial samples in the presence of
inhibitory versus non-inhibitory concentrations of an antimicrobial. However, the absorbance
values for these glucose concentrations values did not fall on the linear portion seen in Figures 6
and 7, so these glucose concentrations would most likely not produce the greatest change in
absorbance between bacterial samples grown in the presence of inhibitory versus non-inhibitory
concentrations of an antimicrobial. These glucose concentrations were selected and used in
future studies because these glucose concentrations produced PAA-CONP absorbance values
greater than 0.2 and were expected to still produce an absorbance difference, even though this
difference may not occur as readily as a concentration of glucose that fell on the linear portion of
the graph in Figures 6 and 7.
Based on the current results of this study, the A395 was expected to decrease as the
concentration of glucose also decreased. Therefore, an anticipated result would be that the A395
of PAA-CONP incubated with glucose oxidase and a bacterial sample containing an inhibitory
concentration of the antimicrobial agent should be higher than the A395 of PAA-CONP incubated
with glucose oxidase and a bacterial sample containing a non-inhibitory concentration of the
antimicrobial agent since the bacterial sample with the non-inhibitory concentration of
antimicrobial agent should have less glucose present in the medium, so less H2O2 would be
produced by this sample relative to the bacterial sample containing an inhibitory concentration of
the antimicrobial agent to oxidize the PAA-CONP. To test this hypothesis, E. coli strain MM 294
was grown in nutrient broth (NB) supplemented with 0.6625mM or 1.325mM glucose in the
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presence or absence of an inhibitory concentration of the antibiotic ampicillin. Comparison of the
A395 of MH Broth samples containing ampicillin showed no significant difference to samples
lacking ampicillin (data not shown), so ampicillin would not interfere with the PAA-CONP
absorbance measurements at 395nm. The E. coli samples were incubated for 2, 4, 6, 8, and 24
hours in the presence or absence of ampicillin (50µg/ml). A second set of 24 hour E. coli
samples that contained or lacked ampicillin was also prepared to determine the turbidity of each
tube to confirm the validity of this experiment. 50µg/ml of ampicillin was determined to be
inhibitory to this E. coli strain based on the lack of turbidity at 24 hours, whereas the sample
lacking ampicillin showed turbidity compared to a sterile NB sample with 50µg/ml ampicillin
(data not shown). The presence/absence of bacterial growth in these 24 hour samples was
confirmed by OD600 measurements (data not shown). The other bacterial samples were then
autoclaved after the time of interest, centrifuged to remove the bacteria from the sample, and
incubated with glucose oxidase and a final dilution of 1:21 of PAA-CONP, and the results were
shown in Figure 8.
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Figure 8: Comparison of the ΔA395 Values of E. coli in the Presence and Absence of
Inhibitory Concentrations of Ampicillin.
a) ∆A395 15 minutes after the addition of glucose oxidase.
b) ∆A395 30 minutes after the addition of glucose oxidase. The absorbance values at 395nm were
measured and calculated by subtracting the absorbance of each sample from both the absorbance
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of the sample before the addition of glucose oxidase and a blank sample containing the same
ampicillin-treated sample in the absence of glucose oxidase. The ∆A395 was then calculated by
subtracting the absorbance of the sample without antibiotic from the sample containing
antibiotic. Note that no ∆A395 sample was prepared for the 8 hour time point for E. coli in the
presence of 0.6625mM glucose. The ∆A395 values shown are the average of the ∆A395 values and
error bars represent the standard deviation of two independent experiments of the same bacterial
culture medium.
The results shown in Figure 8 showed that the difference in absorbance between the E.
coli sample treated with 50µg/ml ampicillin (an inhibitory concentration of ampicillin on E. coli)
and the E. coli sample treated with no ampicillin was indeed detectable. The A395 of the E. coli
sample treated with 50µg/ml ampicillin was similar to the A395 of a sterile medium (nutrient
broth supplemented with 10mg/ml glucose and 50 µg/ml ampicillin, data not shown), indicating
that essentially no glucose metabolism was occurring in the ampicillin-treated E. coli sample,
which was indicative of inhibition of growth by the ampicillin. Detectable ∆A395 occurred earlier
for the 0.6625mM glucose samples (4 hours) compared to the samples containing 1.325mM
glucose (6 hours). Although the samples grown in 0.6625mM glucose could produce a useful
∆A395, the six hour sample in the presence of 0.6625mM glucose and no ampicillin did not show
a detectable absorbance after the addition of glucose oxidase (data not shown), indicating that the
six hour time point could differentiate between inhibitory and non-inhibitory concentrations of
antibiotic based on if there is or is not a detectable A395. Therefore, future bacterial samples
would be incubated for both four hours and six hours in the presence of 0.6625mM glucose. It
should be noted that turbidity was seen as early as four hours in the bacterial samples with no
ampicillin present, and a bacterial pellet could also be detected upon centrifugation of the four
hour sample.
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To compare the results of the current study to the results for one of the gold standard
methods of determining antimicrobial resistance, the Minimum Inhibitory Concentration
(M.I.C.) method, samples of both E. coli and S. aureus were prepared similarly to the protocol
for the M.I.C. method. The bacterial samples were incubated in Nutrient Broth supplemented
with 0.25mg/ml glucose and also supplemented with a range of ampicillin concentrations (as
described in Materials and Methods). Samples were then incubated for either four hours and six
hours, and the results of the absorbance of the PAA-CONP incubated with the four hour and six
hour samples was compared to the turbidity and OD600 of the samples incubated at 24 hours (the
standard incubation time and method of assaying antimicrobial resistance for the M.I.C. method).
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Figure 9: Comparison of PAA-CONP Absorbance with E. coli and S. aureus samples
incubated with a range of ampicillin concentrations for 6hr versus OD600 of 24hr M.I.C.
Samples
a) Absorbance of PAA-CONP at 395nm with E. coli samples incubated for 6 hours compared to
the OD600 of the E. coli samples after 24 hours of incubation.
b) Absorbance of PAA-CONP at 395nm with S. aureus samples incubated 6 hours compared to
the OD600 of the S. aureus samples after 24 hours of incubation.
Note that the 6hr absorbance measurements were measured 15 minutes after glucose oxidase was
added to each sample, and the absorbance measurements were recorded at 395nm. However, the
absorbance measurements at 24 hours were used to assay cell growth and thus measured at
600nm. Note that the absorbance measurements for the 6hr samples were calculated by
subtracting the absorbance of the sample of interest by the absorbance of the same sample before
the addition of glucose oxidase and the absorbance of the blank (sterile control with no glucose
oxidase), and the OD600 values were measured at 24 hours using the sterile control as the blank.
The OD600 of the S. aureus sample with 0μg/ml at 24 hours was in part (b) was 1.704 (too high to
be shown on the graph). 60μg/ml of ampicillin was also inhibitory towards S. aureus growth, and
the PAA-CONP and OD600 measurements for S. aureus at 60μg/ml were similar to other
inhibitory concentrations of ampicillin (data not shown). The results shown are the average
absorbance measurements of the PAA-CONP, and error bars represent the standard deviation of
the PAA-CONP absorbance values for two independent experiments with the same bacterial
culture medium.
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As shown in Figure 9, the absorbance of the PAA-CONP increased as the OD600
decreased. In other words, a higher absorbance of the PAA-CONP occurred when the
concentration of ampicillin inhibited the growth of the bacteria. This trend was seen for both E.
coli and S. aureus, indicating that this trend was not specific for a particular bacterial strain. The
inhibition of bacterial growth was seen as both a lack of turbidity in the bacterial samples (data
not shown) and an OD600 measurement that was about zero when compared to the sterile control.
Note that turbidity was only seen in samples with a measurable OD600 (data not shown).
Furthermore, the absorbance of the PAA-CONP for the concentrations of ampicillin that
inhibited the growth of the bacteria was similar to the absorbance of the sterile control (data not
shown).
However, unlike the data seen in Figure 8, the difference in absorbance measurements
between inhibitory and non-inhibitory concentrations of ampicillin was only slight after four
hours of incubation (data not shown). Furthermore, the absorbance measurements of the
inhibitory concentrations of ampicillin after 6 hours of incubation was not exactly zero for E.
coli. The reason for this variation may have been due to differential growth between bacterial
samples or due to differences in the glucose concentration due to errors in the measurement of
the mass of glucose used during the preparation of the stock glucose solution. Nonetheless, this
data indicated that the results after four hours of incubation were not as reliable as previously
thought. Therefore, six hours of bacterial incubation before testing with the PAA-CONP was
determined to be the ideal incubation time to allow sensitive and reliable A395 measurements.
This data also confirmed that the PAA-CONP absorbance measurements produced similar results
in terms of differentiating between inhibitory and non-inhibitory concentrations of ampicillin
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when compared to turbidity determination and OD600 measurements of the M.I.C. gold standard
method of antimicrobial resistance detection. Therefore, this data indicated that using PAACONP to detect glucose metabolism was a sensitive and reliable method of detecting inhibitory
and non-inhibitory concentrations of ampicillin and also produced results in one quarter of the
amount of time required for the M.I.C. gold standard method of antimicrobial resistance
detection.
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DISCUSSION
The rise of antimicrobial resistance demands quicker, more sensitive methods of detection. A
novel detection method will help to improve the lives of people with bacterial infections by
ensuring the patient receives both the proper and prompter treatment. The method described
herein involving the oxidation of cerium oxide nanoparticles may offer a much more rapid assay
relative to current gold standard methods of antimicrobial resistance detection, which may aid in
quicker treatments for patients. In this study, the use of cerium oxide nanoparticles to detect the
presence of glucose concentrations was shown to be capable of detecting an inhibitory versus
non-inhibitory concentration the antibiotic ampicillin on both E. coli and S. aureus in as little as
six hours of incubation, compared to the 24 hours needed in the M.I.C. and disk diffusion assays
(4). This method only requires a spectrophotometer rather than more expensive machinery and is
also well-suited for high-throughput screening, which would allow the detection of the M.I.C. of
multiple antimicrobials at once. This combination of a reduced incubation time and the ability of
this method to be adapted for high-throughput screening will both save time for the clinical
microbiologist and decrease the time a patient must wait for the most proper therapy. The total
time of sample preparation, incubation (as little as six hours), and absorbance measurements (1530 minutes after the addition of glucose oxidase) would be quick enough to receive results by the
end of the day rather than waiting until the next day. This method may also be useful for testing
the efficacy of multiple concentrations of multiple candidate antimicrobials in the inhibition of
growth of bacteria in high-throughput screening methods. Furthermore, this assay does not
require the use of extreme conditions such as acidic pH or the use of highly reactive chemical
reagents.
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Despite the utility of this cerium oxide nanoparticle based method of antimicrobial
resistance detection, this method has some limitation that should be noted. First, this method
would most likely only be suitable for microorganisms that use glucose as the primary carbon
source, since other carbon sources will be present in the complex growth medium. Furthermore,
like the turbidity method, this method is also dependent on the growth rate of the microbe of
interest, so slower growing microbes may require a longer incubation time to detect differences
in glucose levels. In addition, similarly to the M.I.C. and disk diffusion methods, this assay
requires a pure culture of the pathogenic agent of interest and can only determine if the
antimicrobial agent inhibits bacterial growth, but does not determine the mode of action of the
antimicrobial agent. In other words, this method cannot detect if the antimicrobial agent is
bactericidal (kills the microbe) or bacteriostatic (inhibits the growth of the microbe but does not
kill the microbe). Furthermore, cerium oxide nanoparticles, due to the different preparations
present and lack of a reliable method for quantitation of the amount of cerium oxide
nanoparticles present, would also need to be tested and calibrated to standardize the comparison
of sensitive versus resistant antimicrobial concentrations. For example, absorbance spectra,
differences in the valence state of the preparation, absorbance changes, and the kinetics of
oxidation may vary among different preparations, and all these differences would need to be
accounted for in each nanoparticle preparation. In addition, a large amount of nanoparticles (only
a 1:10 dilution of the stock preparation) was used, which may be an issue in terms of cost and
availability of the nanoparticles. This method also requires at least 6 hours of incubation for
sensitive and reliable absorbance measurements, whereas previously described methods can give
results in as little as three hours (5, 6). Of note, turbidity was actually seen in the non-inhibitory
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concentrations of ampicillin as early as 4 hours, so the early presence of turbidity actually
appeared earlier than expected. Another limitation may be the cost and/or availability of the
reagents to clinical laboratories. Although this method would be less expensive than previously
described novel methods of antimicrobial resistance detection (5, 6), this method still requires
the availability of cerium oxide nanoparticles and glucose oxidase to clinical laboratories. These
reagents, while not exceedingly expensive, can still increase the cost of antimicrobial testing.
However, the increased cost comes with a reduced time to detect antimicrobial resistance, so the
cost-benefit ratio of this method may be determined based on saving money versus the necessity
in receiving the antimicrobial resistance profile for patients.
Despite the limitations posed by this cerium oxide nanoparticle based mode of detection
of antimicrobial resistance, the many benefits offered by this method should make this method
highly considered for not only clinical use but also use for other methods such as drug screening.
For example, this method may also be well-suited in assessing both drug toxicity and the efficacy
of chemotherapeutic agents against cancer cells due to the high metabolic rate of cancer cells
relative to noncancerous cells. Furthermore, data in Figures 6 and 7 show that cerium oxide
nanoparticles may be useful for the quantification of glucose levels, which may have a profound
impact on assessing cell metabolism (although the range of glucose concentrations that result in a
linear trend was not very large according to Figures 6 and 7), or for the quantification of the
concentration of cerium oxide present in the nanoparticle preparation. Most importantly, this
method can reduce antimicrobial resistance testing to 1/6 of the current time needed. Therefore,
this method can allow the rapid screening of antimicrobials to determine the most effective
regimen for patients. This will not only allow the patients to receive proper and prompter
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treatment but also avoid the potential of giving a patient a broad spectrum antibiotic that the
infecting pathogen is unknowingly resistant to while antimicrobial resistance testing is being
performed, which may help prevent unwanted side effects in the patient.

30

REFERENCES
1. Jones RN. (1996) The emergent needs for basic research, education, and surveillance of
antimicrobial resistance. Problems facing the report from the American Society for
Microbiology Task Force on Antibiotic Resistance. Diagn Microbiol Infect Dis 25:153-61.
2. Wise R, Hart T, Cars O, Streulans M, Helmuth R, Huovinen P, Sprenger M (1998)
Antimicrobial resistance. Is a major threat to public health. BMJ 1998;317:609-10.
3. World Health Organization Fact Sheet (2011) Antimicrobial Resistance.
4. Forbes BA, Sahm DF, Weissfeld AS (2007) Bailey & Scott’s Diagnostic Microbiology.
Mosby Elsevier 12:187-214.
5. Nath S, Kaittanis C, Tinkham A, Perez JM (2008) Dextran-coated gold nanoparticles for the
assessment of antimicrobial susceptibility. Anal Chem 80:1033-8.
6. Kaittanis C, Nath S, Perez JM (2008) Rapid nanoparticle-mediated monitoring of bacterial
metabolic activity and assessment of antimicrobial susceptibility in blood with magnetic
relaxation. PLoS One 3:e3253.
7. Das M, Patil S, Bhargava N, Kang JF, Riedel LM, Seal S, Hickman JJ (2007) Auto-catalytic
ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials
28:1918.
8. Asati A, Santra S, Kaittanis C, Nath S, Perez JM (2009) Oxidase activity of polymer-coated
cerium oxide nanoparticles. Angew Chem Int Ed Engl 48:2308-12.
9. Tsunekawa S, Sivamohan R, Ohsuna T, Kasuya A, Takahashi H, Tohji K (1999) Ultraviolet
absorption spectra of CeO2 nano-particles. Materials Science Forum 315–317:439–45.
10. Keilin D, Hartree EF (1948) Properties of glucose oxidase (notatin). Biochem J 42:221-9.

31

